Sarah Cannon Development Innovations is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon Development Innovations has participated in 1 clinical trials.
Therapeutic areas: Metastatic Melanoma and Other Solid Tumors.
Sponsors: Bayer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Development Innovations has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Development Innovations has 1 clinical trials on record. Their work covers Metastatic Melanoma and Other Solid Tumors.
Sarah Cannon Development Innovations has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.